会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • IN SITU LYSIS OF CELLS IN LATERAL FLOW IMMUNOASSAYS
    • 在横向流免疫测定中细胞的原位裂解
    • WO2010009206A2
    • 2010-01-21
    • PCT/US2009/050653
    • 2009-07-15
    • RAPID PATHOGEN SCREENING, INC.VANDINE, Robert, W.BABU, Uma, MaheshSAMBURSKY, Robert, P.
    • VANDINE, Robert, W.BABU, Uma, MaheshSAMBURSKY, Robert, P.
    • G01N33/53G01N33/538
    • G01N33/558C12Q1/6834C12Q2565/137
    • Devices and methods incorporate lysis agents into a point-of-care testing device. The sample is loaded, and then the sample travels until it encounters a lysis agent. The lysis agent is preferably pre-loaded onto the collection device. In a preferred embodiment, the initially lysis agent is localized between the sample application zone and the conjugate zone. The lysis agent is preferably soluble or miscible in the sample transport liquid, and the lysis agent is solubilized and activated upon contact with the sample transport liquid. The sample transport liquid then contains both lysis agent in solution or suspension and sample components in suspension. Any lysis-susceptible components in a sample, then being exposed in suspension to the lysis agent, are themselves lysed in situ. The running buffer then carries the analyte, including any lysis-freed components, to the detection zone.
    • 装置和方法将裂解剂结合到护理点测试装置中。 装载样本,然后样本移动直到遇到裂解剂。 裂解剂优选预加载到收集装置上。 在一个优选的实施方案中,最初的溶解剂位于样品施加区和缀合物区之间。 裂解剂优选可溶于或可混溶于样品运输液体中,裂解剂在与样品运输液体接触时溶解并活化。 样品输送液体然后包含溶液或悬浮液中的溶解剂和悬浮液中的样品组分。 样品中任何溶解敏感组分,然后暴露于悬浮液中溶解试剂本身就地溶解。 然后运行缓冲液将分析物(包括任何无溶解成分)携带到检测区。
    • 9. 发明申请
    • IN SITU LYSIS OF CELLS IN LATERAL FLOW IMMUNOASSAYS
    • 在流动免疫中的细胞的原位分析
    • WO2010009206A3
    • 2010-05-14
    • PCT/US2009050653
    • 2009-07-15
    • RAPID PATHOGEN SCREENING INCVANDINE ROBERT WBABU UMA MAHESHSAMBURSKY ROBERT P
    • VANDINE ROBERT WBABU UMA MAHESHSAMBURSKY ROBERT P
    • G01N33/53G01N33/538
    • G01N33/558C12Q1/6834C12Q2565/137
    • Devices and methods incorporate lysis agents into a point-of-care testing device. The sample is loaded, and then the sample travels until it encounters a lysis agent. The lysis agent is preferably pre-loaded onto the collection device. In a preferred embodiment, the initially lysis agent is localized between the sample application zone and the conjugate zone. The lysis agent is preferably soluble or miscible in the sample transport liquid, and the lysis agent is solubilized and activated upon contact with the sample transport liquid. The sample transport liquid then contains both lysis agent in solution or suspension and sample components in suspension. Any lysis-susceptible components in a sample, then being exposed in suspension to the lysis agent, are themselves lysed in situ. The running buffer then carries the analyte, including any lysis-freed components, to the detection zone.
    • 设备和方法将裂解剂并入护理点测试装置。 加载样品,然后样品运行直到遇到裂解剂。 裂解剂优选预加载到收集装置上。 在优选的实施方案中,最初的裂解剂定位在样品施用区和缀合区之间。 裂解剂优选在样品输送液体中可溶或可混溶,并且裂解剂在与样品输送液体接触时溶解和活化。 样品输送液体随后含有溶液或悬浮液中的裂解剂和悬浮液中的样品组分。 样品中任何裂解敏感的组分然后暴露于溶解剂的悬浮液中,它们本身就是裂解的。 运行缓冲液然后将分析物(包括任何无裂解释放的组分)携带到检测区。